Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 10Observational 2

Sponsor

Cancer Type

Plasma cell 2Lymphoid 2

Conditions

Multiple Myeloma 3Lymphoma 2Neoplasms, Plasma Cell 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1

Interventions

Gene Expression Profiling 11Surveys and Questionnaires 9Polymerase Chain Reaction 9Immunohistochemistry 9Amplified Fragment Length Polymorphism Analysis 9Flow Cytometry 8Psychiatric Rehabilitation 7Microarray Analysis 6Rituximab 5Interviews as Topic 4Cytogenetic Analysis 4Blood Specimen Collection 4Biopsy 4Therapeutics 3Immunologic Techniques 3Gene Rearrangement 3Drug Therapy 3Doxorubicin 3Data Collection 3Cyclophosphamide 3plerixafor 2Vincristine 2Prednisone 2Positron-Emission Tomography 2Phlebotomy 2Pharmacogenomic Testing 2Observation 2Neuropsychological Tests 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Lymphoma × plerixafor × Clear all
NCT01738373 2015-03-23

Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation

Sanofi

Completed
262 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT01700608 2012-10-04

Prospective Observational Study on Plerixafor After Chemotherapy

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Completed
27 enrolled
LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡